Free Trial

Tarsus Pharmaceuticals (TARS) SEC Filings & 10K Form

Tarsus Pharmaceuticals logo
$51.01 -0.32 (-0.62%)
Closing price 03/26/2025 04:00 PM Eastern
Extended Trading
$51.00 -0.01 (-0.02%)
As of 03/26/2025 05:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Tarsus Pharmaceuticals SEC Filings

DateFilerForm TypeView
03/24/2025
4:35 PM
Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
8:49 PM
Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
8:48 PM
Farrow Jeffrey S (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
8:48 PM
Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
8:48 PM
Tarsus Pharmaceuticals (Issuer)
Whitfield Dianne C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
8:49 PM
Tarsus Pharmaceuticals (Issuer)
Wahl Bryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
8:49 PM
Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
3:29 PM
Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
3:30 PM
Farrow Jeffrey S (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
3:35 PM
Tarsus Pharmaceuticals (Subject)
Whitfield Dianne C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
3:18 PM
Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
3:21 PM
Tarsus Pharmaceuticals (Subject)
Wahl Bryan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
3:11 PM
Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
2:24 PM
Tarsus Pharmaceuticals (Subject)
Wahl Bryan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
2:27 PM
Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
2:22 PM
Tarsus Pharmaceuticals (Subject)
Whitfield Dianne C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
2:23 PM
Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
2:12 PM
Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
2:12 PM
Farrow Jeffrey S (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/18/2025
8:38 PM
Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
8:39 PM
Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
8:39 PM
Tarsus Pharmaceuticals (Issuer)
Wahl Bryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
8:39 PM
Tarsus Pharmaceuticals (Issuer)
Whitfield Dianne C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
8:40 PM
Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
8:40 PM
Farrow Jeffrey S (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
3:26 PM
Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/18/2025
3:26 PM
Tarsus Pharmaceuticals (Subject)
Wahl Bryan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/18/2025
3:31 PM
Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/18/2025
3:20 PM
Tarsus Pharmaceuticals (Subject)
Whitfield Dianne C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2025
3:37 PM
Tarsus Pharmaceuticals (Filer)
Form 424B5
03/13/2025
3:40 PM
Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2025
3:26 PM
Tarsus Pharmaceuticals (Filer)
Form 424B5
03/07/2025
3:17 PM
Lin Elizabeth Yeu (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:17 PM
Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:18 PM
Tarsus Pharmaceuticals (Issuer)
Wahl Bryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:19 PM
Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:19 PM
Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
6:07 AM
Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
11:22 AM
Cowen Financial Products LLC (Filed by)
Tarsus Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
01/17/2025
4:08 PM
Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
7:30 AM
Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
A brutally honest economic warning for 2025 (see proof) (Ad)

New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked side-by-side with figures like Warren Buffett, Alan Greenspan, Ron Paul, Jim Rickards, and Steve Forbes, to name but a few) says....

12/19/2024
4:03 PM
Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
2:05 PM
Cormorant Asset Management, LP (Filed by)
Tarsus Pharmaceuticals (Subject)
Form SC 13G/A
11/13/2024
3:06 PM
Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
3:40 PM
Lin Elizabeth Yeu (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
9:26 AM
Frazier Life Sciences IX, L.P. (Filed by)
Tarsus Pharmaceuticals (Subject)
Form SC 13G/A
11/05/2024
3:06 PM
Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
1:00 PM
Tarsus Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/21/2024
3:11 PM
BlackRock, Inc. (Filed by)
Tarsus Pharmaceuticals (Subject)
Form SC 13G/A
10/02/2024
4:27 PM
Morrison Scott W (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
4:52 PM
Morrison Scott W (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
3:34 PM
LINK WILLIAM J PHD (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:21 PM
Tarsus Pharmaceuticals (Issuer)
YARNO WENDY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:22 PM
CHAUDHURI BHASKAR (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:23 PM
Morrison Scott W (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:24 PM
Lin Elizabeth Yeu (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:25 PM
LINK WILLIAM J PHD (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:26 PM
Goldberg Andrew D. (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:26 PM
Crane Rosemary A (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
3:26 PM
Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
4:44 PM
CHAUDHURI BHASKAR (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:45 PM
Goldberg Andrew D. (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:33 PM
Lin Elizabeth Yeu (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:38 PM
Tarsus Pharmaceuticals (Issuer)
YARNO WENDY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:40 PM
Crane Rosemary A (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:28 PM
LINK WILLIAM J PHD (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:30 PM
Morrison Scott W (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
3:12 PM
Tarsus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2024
3:24 PM
Tarsus Pharmaceuticals (Filer)
Form DEF 14A
04/26/2024
3:25 PM
Tarsus Pharmaceuticals (Filer)
Form DEFA14A
04/23/2024
7:34 AM
Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
1:56 PM
Tarsus Pharmaceuticals (Subject)
Trevejo Jose M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/28/2024
1:06 PM
Tarsus Pharmaceuticals (Subject)
Trevejo Jose M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:TARS) was last updated on 3/27/2025 by MarketBeat.com Staff
From Our Partners